Non-clinical pharmacology, pharmacokinetics, and safety evaluation of TAX2, a first-in-class peptide targeting the TSP-1/CD47 matricellular axis.

AP-01 - Apmonia Therap

http://www.ncbi.nlm.nih.gov/pubmed/42069155

Albin Jeanne; Auberi Henry; Aurélie Moniot; Mariem Ghoula; Marion Etiennot; Sonia Poli; Stéphane Dedieu

May 3, 2026